Literature DB >> 20006769

Brown recluse spider (Loxosceles reclusa) envenomation leading to acute hemolytic anemia in six adolescents.

Jenny McDade1, Banu Aygun, Russell E Ware.   

Abstract

Loxosceles reclusa (brown recluse spider) bites often cause local envenomation reactions; however, acute hemolysis from systemic loxoscelism is rare. To highlight this important diagnostic consideration for unexplained hemolysis in areas endemic for brown recluse spiders, we report on 6 adolescents with acute hemolytic anemia from presumed L reclusa bites.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20006769      PMCID： PMC4902007          DOI： 10.1016/j.jpeds.2009.07.021

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  10 in total

Review 1.  Loxoscelism.

Authors:  J M Futrell
Journal:  Am J Med Sci       Date:  1992-10       Impact factor: 2.378

2.  Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation.

Authors:  Kátia C de Oliveira; Rute M Gonçalves de Andrade; Roxane M F Piazza; Jorge M C Ferreira; C W van den Berg; Denise V Tambourgi
Journal:  Toxicon       Date:  2005-03-15       Impact factor: 3.033

Review 3.  Loxoscelism.

Authors:  David L Swanson; Richard S Vetter
Journal:  Clin Dermatol       Date:  2006 May-Jun       Impact factor: 3.541

Review 4.  Brown spiders and loxoscelism.

Authors:  Paulo Henrique da Silva; Rafael Bertoni da Silveira; Márcia Helena Appel; Oldemir Carlos Mangili; Waldemiro Gremski; Silvio Sanches Veiga
Journal:  Toxicon       Date:  2004-12-01       Impact factor: 3.033

Review 5.  Coombs-positive hemolytic anemia secondary to brown recluse spider bite: a review of the literature and discussion of treatment.

Authors:  David R Lane; Jeremy S Youse
Journal:  Cutis       Date:  2004-12

6.  Severe systemic reaction to Loxosceles reclusa spider bites in a pediatric population.

Authors:  Lama M Elbahlawan; Gregory L Stidham; Mark C Bugnitz; Stephanie A Storgion; Michael W Quasney
Journal:  Pediatr Emerg Care       Date:  2005-03       Impact factor: 1.454

7.  Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway.

Authors:  D V Tambourgi; F C Magnoli; V R Von Eickstedt; Z C Benedetti; V L Petricevich; W D da Silva
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

8.  Mechanism of induction of complement susceptibility of erythrocytes by spider and bacterial sphingomyelinases.

Authors:  Denise V Tambourgi; Marcelo De Sousa Da Silva; Stephen J Billington; Rute M Gonçalves De Andrade; Fábio C Magnoli; J Glenn Songer; Carmen W Van Den Berg
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

9.  Loxosceles venom-induced cytokine activation, hemolysis, and acute kidney injury.

Authors:  A L de Souza; C M Malaque; J Sztajnbok; C C Romano; A J Duarte; A C Seguro
Journal:  Toxicon       Date:  2007-09-02       Impact factor: 3.033

10.  Sudden unexplained hemolysis occurring in an infant due to presumed Loxosceles envenomation.

Authors:  Mark A Hostetler; William Dribben; David B Wilson; William J Grossman
Journal:  J Emerg Med       Date:  2003-10       Impact factor: 1.484
  10 in total
  10 in total

1.  Brown Recluse Spider Bites in Patients With Neutropenia: A Single-institution Experience.

Authors:  Diego R Hijano; Daniel Otterson; Maysam R Homsi; Yin Su; Li Tang; Jeannette Kirby; Miguela A Caniza
Journal:  J Pediatr Hematol Oncol       Date:  2019-01       Impact factor: 1.289

2.  Viscerocutaneous Loxoscelism in an Adult with Acute Generalized Exanthematous Pustulosis.

Authors:  Mark Mueller; Emily Doucette; Seth Freeman; Amy Williams; Erik Lindbloom
Journal:  Mo Med       Date:  2014 Mar-Apr

3.  Acute Hemolytic Anemia Caused by Loxoscelism Treated With Plasmapheresis: A Case Report.

Authors:  Stephanie Harry; Emily Brugioni; Sheshadri Madhusudhana
Journal:  J Med Cases       Date:  2022-04-23

4.  Rare case of dermonecrosis caused by a recluse spider bite in Europe.

Authors:  Monique Cachia; Liam Mercieca; Charles Mallia Azzopardi; Michael J Boffa
Journal:  BMJ Case Rep       Date:  2016-07-20

5.  Loxosceles gaucho venom-induced acute kidney injury--in vivo and in vitro studies.

Authors:  Rui V Lucato; Regina C R M Abdulkader; Katia C Barbaro; Glória E Mendes; Isac Castro; Maria A S F Baptista; Patrícia M Cury; Denise M C Malheiros; Nestor Schor; Luis Yu; Emmanuel A Burdmann
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

Review 6.  The Clinical Pictures of Autoimmune Hemolytic Anemia.

Authors:  Charles H Packman
Journal:  Transfus Med Hemother       Date:  2015-09-11       Impact factor: 3.747

7.  Defining the complex phenotype of severe systemic loxoscelism using a large electronic health record cohort.

Authors:  Jamie R Robinson; Vanessa E Kennedy; Youssef Doss; Lisa Bastarache; Joshua Denny; Jeremy L Warner
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

8.  Brown Recluse spider bite mediated hemolysis: clinical features, a possible role for complement inhibitor therapy, and reduced RBC surface glycophorin A as a potential biomarker of venom exposure.

Authors:  Eric A Gehrie; Hui Nian; Pampee P Young
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

9.  Acute kidney injury and dermonecrosis after Loxosceles reclusa envenomation.

Authors:  A Nag; J Datta; A Das; A K Agarwal; D Sinha; S Mondal; T Ete; A Chakraborty; S Ghosh
Journal:  Indian J Nephrol       Date:  2014-07

10.  Low Health System Performance, Indigenous Status and Antivenom Underdosage Correlate with Spider Envenoming Severity in the Remote Brazilian Amazon.

Authors:  Vanderson Souza Sampaio; André Alexandre Gomes; Iran Mendonça Silva; Jacqueline Sachett; Luiz Carlos Lima Ferreira; Sâmella Oliveira; Meritxell Sabidò; Hipócrates Chalkidis; Maria Graças Vale Barbosa Guerra; Jorge Luis Salinas; Fan Hui Wen; Marcus Vinícius Guimarães Lacerda; Wuelton Marcelo Monteiro
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.